Skip to main content

High-Throughput and Cost-Effective Genome-wide Microsatellite Genotyping of Two Novel Cystic Fibrosis Mutant Mouse Strains

Buy Article:

$107.14 + tax (Refund Policy)

Whole-genome scan experiments have been used extensively for the characterization of the classical laboratory inbred strains of mice generating panels of polymorphic and equally spaced microsatellite markers. In this report we describe the implementation of informative microsatellite markers in the genetic characterization of two novel inbred cystic fibrosis mutant strains, CF/1-CftrTgH(neoim)1Hgu and CF/3-CftrTgH(neoim)1Hgu, with a straightforward, time-efficient, and cost-effective genotyping procedure utilizing direct blotting electrophoresis. A whole-genome scan experiment was undertaken by selecting a panel of 105 microsatellite markers on the basis of spacing and polymorphism in the strains C57BL/6J, DBA/2J, and BALB/c, which were further used for the generation of congenic CftrTgH(neoim)1Hgu mutant animals. The genome-wide strain distribution of microsatellite alleles between the two inbred cystic fibrosis strains differed significantly from the three classical inbred strains. Moreover, using the Wagner parsimony method, we were able to generate a tree whereby the relatedness of the two novel inbred strains to the three classic laboratory inbred strains was determined. For C57BL/6J, DBA/2J, and BALB/c the results of the parsimony analysis were in agreement with the previously documented history of the inbred strains, whereas both cystic fibrosis inbred strains were placed as the most deeply divergent strains.

Keywords: COST-EFFECTIVE; CYSTIC FIBROSIS; DIRECT BLOTTING ELECTROPHORESIS; HIGH THROUGHPUT; INBRED; MUTANT MICE; WHOLE-GENOME SCAN

Document Type: Research Article

Publication date: 01 March 2004

More about this publication?
  • Genome Letters is an international peer-reviewed journal with a wide-ranging coverage, consolidates research activities in all aspects of genome science, genome technology, bioinformatics, biotechnology and medicine into a single, and unique reference source. Genome Letters provides the means for scientists, researchers, medical doctors, clinicians and biotechnologists to publish original rapid communications, full papers and timely state-of-the-art reviews encompassing the fundamental and applied research in all areas of the genome science and technology. Highest priority will be given to short communications reporting important new scientific and technological findings. Short communications on new findings with breakthrough results will be considered for accelerated publication though authors should provide a brief description why the manuscript be considered for fast tracking.
  • Editorial Board
  • Information for Authors
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content